β¨ Medicine Consents and Social Security Notice
11 SEPTEMBER 2014 NEW ZEALAND GAZETTE, No. 109 3033
Schedule
Product: Actemra
Active Ingredient: Tocilizumab 20mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Chugai Pharmaceutical Co Limited, Tochigi, Japan
Product: Ezemibe
Active Ingredient: Ezetimibe 10mg
Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State, India
Dated this 4th day of September 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go5647
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Canesten Bifonazole Anti-Fungal Cream
Active Ingredient: Bifonazole 10mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Kern Pharma SL, Barcelona, Spain
Dated this 4th day of September 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 of September 2013).
go5646
Social Security Act 1964
Maximum Contribution Applying in Each Territorial Local Authority Region from 1 October 2014
Under section 152 of the Social Security Act 1964, the Director-General of Health is required to notify the maximum contribution that applies in each region for long-term aged residential care.
The maximum contribution is the maximum weekly amount (inclusive of GST) that a resident assessed as requiring long-term residential care (through a needs assessment and service coordination agency) is required to pay for contracted care services provided to them in the region in which their rest home or continuing care hospital is located.
The maximum contribution is the same for all residents regardless of the type of contracted care services they receive. It is equivalent to the rest home contract price applying to residential care facilities in each territorial local authority region.
The maximum contribution set by this notice applies from 1 October 2014 and replaces the previous maximum contribution notice published in the New Zealand Gazette, 19 June 2014, No. 65, page 1857.
The daily GST exclusive contract price for rest home services has been increased by 5%, GST has been added and the result has been multiplied by seven to determine the new maximum contribution. The calculations are rounded to two decimal places at each step.
| Region: Territorial Local Authority | District Health Board | Maximum Contribution Weekly (GST Inclusive) |
|---|---|---|
| Far North District | Northland | $873.04 |
| Whangarei District | Northland | $896.28 |
| Kaipara District | Northland | $873.04 |
| Rodney District | Waitemata | $922.67 |
| North Shore City | Waitemata | $951.44 |
| Waitakere City | Waitemata | $928.41 |
| Auckland City | Auckland | $955.29 |
| Manukau City | Counties Manukau | $943.74 |
| Papakura District | Counties Manukau | $922.67 |
| Franklin District | Counties Manukau | $893.48 |
| Thames-Coromandel District | Waikato | $877.10 |
| Hauraki District | Waikato | $877.10 |
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare4 September 2014
Medicines Act, New Medicines, Distribution Consent, Actemra, Ezemibe
- STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health
π₯ Consent to Distribution of a New Medicine
π₯ Health & Social Welfare4 September 2014
Medicines Act, New Medicine, Distribution Consent, Canesten Bifonazole Anti-Fungal Cream
- STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health
π₯ Maximum Contribution for Long-Term Aged Residential Care
π₯ Health & Social WelfareSocial Security Act, Residential Care, Maximum Contribution, Territorial Local Authority Regions
NZ Gazette 2014, No 109